Basic Information Experimental Physicochemical Property Pharmacokinetic/Toxicokinetic Property Maximum Dosage Drug Property Radar Chart

Basic Information

Drug ID DDPD02325 ...
Drug Name Isopropyl alcohol
Molecular Weight 60.095
Molecular Formula C3H8O
CAS Number 67-63-0
SMILES CC(C)O
External Links
DRUGBANK DB02325
T3DB T3D4699
PubChem Compound 3776
PDR 12

Experimental Physicochemical Property

Property Name Property Value Unit Raw Value Raw Unit Reference
Log P 0.05 - 0.05 - HANSCH,C ET AL. (1995)
Boiling Point 82.3 ℃ 82.3 ℃ PhysProp
Melting Point -89.5 ℃ -89.5 ℃ PhysProp
Water Solubility 1000000.0 mg/L 1000000 mg/L RIDDICK,JA ET AL. 1986)
pKa 17.1 - 17.1 - SERJEANT,EP & DEMPSEY,B (1979)

Pharmacokinetic/ Toxicokinetic Property

Not Available

Maximum Dosage

Property Name Property Value Unit Raw Value Raw Unit Annotation Frequency Brand Name Component Reference
Max dose for children 40.0 mg 40 mg subcutaneous injection, SC qow Humira adalimumab PDR
Max dose for children 40.0 mg 40 mg subcutaneous injection, SC qw Humira adalimumab PDR
Max dose for children 40.0 mg 40 mg subcutaneous injection, SC qow Humira adalimumab PDR
Max dose for children 40.0 mg 40 mg subcutaneous injection, SC qow Humira adalimumab PDR
Max dose for children 20.0 mg 20 mg subcutaneous injection, SC qow Humira adalimumab PDR
Max dose for children 20.0 mg 20 mg subcutaneous injection, SC qow Humira adalimumab PDR
Max dose for children 20.0 mg 20 mg subcutaneous injection, SC qow Humira adalimumab PDR
Max dose for children 20.0 mg 20 mg subcutaneous injection, SC qow Humira adalimumab PDR
Max dose for children 40.0 mg 40 mg subcutaneous injection, SC qow Humira adalimumab PDR
Max dose for children 20.0 mg 20 mg subcutaneous injection, SC qow Humira adalimumab PDR
Max dose for children 20.0 mg 20 mg subcutaneous injection, SC qow Humira adalimumab PDR
Max dose for children 20.0 mg 20 mg subcutaneous injection, SC qow Humira adalimumab PDR
Max dose for children 10.0 mg 10 mg subcutaneous injection, SC qow Humira adalimumab PDR
Max dose for adolescents 40.0 mg 40 mg subcutaneous injection, SC qow Humira adalimumab PDR
Max dose for adolescents 40.0 mg 40 mg subcutaneous injection, SC qw Humira adalimumab PDR
Max dose for adolescents 40.0 mg 40 mg subcutaneous injection, SC qow Humira adalimumab PDR
Max dose for adolescents 40.0 mg 40 mg subcutaneous injection, SC qow Humira adalimumab PDR
Max dose for adolescents 20.0 mg 20 mg subcutaneous injection, SC qow Humira adalimumab PDR
Max dose for adolescents 20.0 mg 20 mg subcutaneous injection, SC qow Humira adalimumab PDR
Max dose for adolescents 20.0 mg 20 mg subcutaneous injection, SC qow Humira adalimumab PDR
Max dose for adults 40.0 mg 40 mg subcutaneous injection, SC qow Humira adalimumab PDR
Max dose for adults 40.0 mg 40 mg subcutaneous injection, SC qow Humira adalimumab PDR
Max dose for geriatric 40.0 mg 40 mg subcutaneous injection, SC qow Humira adalimumab PDR
Max dose for geriatric 40.0 mg 40 mg subcutaneous injection, SC qow Humira adalimumab PDR
Max dose for adults 1.66666666666667 mg/day 150 mg/dose subcutaneous injection, SC q3m Skyrizi risankizumab-rzaa PDR
Max dose for geriatric 1.66666666666667 mg/day 150 mg/dose subcutaneous injection, SC q3m Skyrizi risankizumab-rzaa PDR

Drug Property Radar Chart

...

Note: Center: Q1-1.5*IQR, Edge: Q3+1.5*IQR; Q1: Quantile 1, Q3: Quantile 3, IQR: Q3-Q1